Lexeo Therapeutics (LXEO) Interest Coverage Ratio (2022 - 2026)
Lexeo Therapeutics' (LXEO) quarterly Interest Coverage Ratio came in at 1313.71 in Q1 2026, down 8.81% year-on-year from 1440.65 in Q1 2025, and down 13.66% quarter-over-quarter from 1155.8 in Q4 2025.
Lexeo Therapeutics (LXEO) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has disclosed Interest Coverage Ratio across 5 years of filings, most recently posting 1313.71 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 1313.71, down 8.81% year-over-year; the trailing twelve-month figure through Mar 2026 was 1164.11 (down 377.81% YoY), and the FY2025 annual result was 1150.07, down 662.23% from the prior year.
- Interest Coverage Ratio came in at 1313.71 for Q1 2026 at Lexeo Therapeutics, down from 1155.8 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1923.77 in Q4 2024 to a low of 1313.71 in Q1 2026.
- The 5-year median for Interest Coverage Ratio is 629.49 (2024), against an average of 559.42.
- Across the five-year window, Interest Coverage Ratio surged 742.37% in 2024 and tumbled 160.08% in 2025, its largest moves.
- Lexeo Therapeutics' Interest Coverage Ratio stood at 281.43 in 2022, then fell by 6.42% to 299.48 in 2023, then surged by 742.37% to 1923.77 in 2024, then sank by 160.08% to 1155.8 in 2025, then slipped by 13.66% to 1313.71 in 2026.
- The last three Interest Coverage Ratio figures came in at 1313.71 (Q1 2026), 1155.8 (Q4 2025), and 984.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Lexeo Therapeutics | 405.92 Mn | 212.88 Mn | - | -1,313.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,313.71 |
| Dec 31, 2025 | -1,155.80 |
| Sep 30, 2025 | -984.00 |
| Jun 30, 2025 | -1,227.52 |
| Mar 31, 2025 | -1,207.32 |
| Dec 31, 2024 | 1,923.77 |
| Sep 30, 2024 | -901.23 |
| Jun 30, 2024 | -672.86 |
| Mar 31, 2024 | -629.49 |
| Dec 31, 2023 | -299.48 |
| Sep 30, 2023 | -389.87 |
| Jun 30, 2023 | -263.68 |
| Mar 31, 2023 | -385.80 |
| Dec 31, 2022 | -281.43 |
| Sep 30, 2022 | -602.83 |